The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Ophthalmic Viscoelastic Devices Market In 2026 And 2030?
The ophthalmic viscoelastic devices market has experienced consistent growth in recent years. It is anticipated to expand from $2.72 billion in 2025 to $2.85 billion in 2026, at a compound annual growth rate (CAGR) of 4.7%. The historical growth in this market can be attributed to factors such as the increasing prevalence of cataract surgeries, a growing aging population, rising adoption of intraocular surgical procedures, the expansion of ophthalmology clinics, and improved access to eye care services.
The ophthalmic viscoelastic devices market is projected to experience robust expansion in the coming years. It is forecast to reach $3.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This projected growth during the forecast period is primarily driven by factors such as the escalating demand for superior ophthalmic surgical results, a heightened emphasis on minimizing complications, the proliferation of sophisticated ophthalmic surgery facilities, increasing capital directed towards eye care infrastructure, and the growing integration of novel viscoelastic substances. Key trends anticipated in the forecast period encompass the wider acceptance of advanced viscoelastic formulations, a surge in the need for dual-property OVDs, an increasing concentration on superior tissue safeguarding, the expansion of minimally invasive ophthalmic procedures, and improvements in shelf stability alongside biocompatibility characteristics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10665&type=smp
What Core Drivers Are Transforming The Ophthalmic Viscoelastic Devices Market?
The ophthalmic viscoelastic devices market is anticipated to grow due to an increase in the number of ophthalmic surgeries. These surgeries cover various procedures performed on the eyes, including operations for cataracts, corneal transplants, and the repair of retinal detachment. Ophthalmic viscoelastic devices (OVDs) are utilized in these eye surgeries to maintain surgical space, protect sensitive ocular structures, assist with surgical maneuvers, and ensure clear visualization, owing to their viscous and elastic characteristics. This contributes to better surgical outcomes and minimizes complications such as tissue trauma and issues during surgery. For instance, data from May 2023, as per the National Health Service England, a UK-based publicly funded healthcare system, showed that cataract surgery makes up 6% of all surgeries performed annually, with more than 450,000 procedures conducted. Forecasts project a 25% rise in cataract surgeries by 2027 and a substantial 50% increase by 2035. Therefore, the growing volume of ophthalmic surgeries is a key driver for the expansion of the ophthalmic viscoelastic devices market.
What Are The Major Segment Categories Within The Ophthalmic Viscoelastic Devices Market?
The ophthalmic viscoelastic devices market covered in this report is segmented –
1) By Product Type: Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic
2) By Application: Cataract Surgery, Glaucoma Surgery, Corneal Transplant, Vitreoretinal Surgery
3) By End User: Hospital, Ophthalmology Clinics, Other End-Users
Subsegments:
1) By Cohesive Ophthalmic Viscoelastic: Sodium Hyaluronate, Hyaluronic Acid
2) By Dispersive Ophthalmic Viscoelastic: Sodium Chondroitin Sulfate, Dispersive Hydrogel
What Trends Are Shaping The Ophthalmic Viscoelastic Devices Market Structure?
Leading firms within the ophthalmic viscoelastic devices market are prioritizing technological innovations, such as line implant-free system solutions, to enhance the accuracy of surgical procedures and patient results in eye operations. An advanced line implant-free system represents a state-of-the-art technology that streamlines medical interventions without requiring invasive implants, thus providing non-surgical approaches for diverse treatments and procedures. As an illustration, during April 2023, Bausch + Lomb Corporation, an eye health company based in the US, introduced both the StableVisc cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc Viscoelastic System. StableVisc, functioning as a cohesive OVD, assists in preserving space within the eye’s anterior chamber, thereby enabling surgeons to remove and substitute the clouded natural lens. The TotalVisc Viscoelastic System encompasses both StableVisc and ClearVisc, which is a dispersive OVD, offering protection to ocular tissue throughout surgical procedures. These offerings incorporate sodium hyaluronate and sorbitol, a distinctive chemical combination proven in laboratory studies to provide superior free radical scavenging capabilities compared to other OVDs. TotalVisc OVD provides both mechanical and chemical protection through its dual-action mechanism.
Which Organizations Are Operating Within The Ophthalmic Viscoelastic Devices Market?
Major companies operating in the ophthalmic viscoelastic devices market are Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech AB, Carl Zeiss Meditec AG, Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Alcon Inc., Beaver-Visitec International, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.
Access The Complete Ophthalmic Viscoelastic Devices Market Report:
Which Regional Market Leads The Ophthalmic Viscoelastic Devices Market?
North America was the largest region in the ophthalmic viscoelastic devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Ophthalmic Viscoelastic Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Ophthalmic Viscoelastic Devices Market 2026, By The Business Research Company
Ophthalmic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report
Diagnostic And Monitoring Ophthalmic Devices And Equipment Market 2026
Ophthalmic Packaging Market Report 2026
https://www.thebusinessresearchcompany.com/report/ophthalmic-packaging-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model